This bill expresses support for designating May 17, 2026, as "DIPG Awareness Day" to raise awareness and encourage increased research funding for diffuse intrinsic pontine glioma and other pediatric cancers.
Debbie Dingell
Representative
MI-6
This resolution expresses support for designating May 17, 2026, as "DIPG Awareness Day" to highlight the devastating impact of diffuse intrinsic pontine glioma (DIPG) and other pediatric cancers. The bill calls for increased federal funding for pediatric cancer research, given the grim prognosis for DIPG patients. It also urges research funders to prioritize diseases with high mortality rates and significant years of life lost.
New Resolution Designates May 17, 2026, as DIPG Awareness Day to Tackle Pediatric Cancer Funding Gaps
This resolution establishes May 17, 2026, as a national day of awareness for Diffuse Intrinsic Pontine Glioma (DIPG), a rare and aggressive childhood brain cancer. Beyond just marking a date on the calendar, the bill formally recognizes the stagnant progress in treating this disease—where the prognosis hasn't improved in 40 years—and calls for a fundamental shift in how the government and private sectors prioritize medical research funding. By focusing on DIPG, which is the leading cause of childhood cancer deaths, the legislation aims to bridge the gap between the severity of pediatric diseases and the resources currently allocated to solve them.
The Data Behind the Diagnosis
The resolution lays out some sobering math that highlights why this specific cancer is being singled out. DIPG affects between 200 and 400 children in the U.S. every year, and the median survival time after diagnosis is just nine months. Because it strikes so early in life, the bill notes that approximately 24,000 years of 'person life' are lost annually to this disease. For a family in the middle of this crisis, these aren't just statistics; they represent a total lack of options for a child. By codifying these facts, the resolution sets a benchmark for why pediatric brain tumor research needs a more urgent seat at the federal funding table.
Changing the Funding Playbook
One of the most practical shifts proposed in this bill involves how research grants are actually handed out. It urges public and private funders to give 'greater weight' to a cancer’s mortality rate and the total years of life lost when they are reviewing applications. Currently, research funding can sometimes follow the most common diseases rather than the most lethal ones. If you are a researcher working on a cure for a rare but deadly pediatric tumor, this provision is designed to help your grant application stand out by emphasizing the high 'cost' of the disease in terms of lost potential and human life.
A Roadmap for Pediatric Care
While the primary focus is on research, the resolution also advocates for a more comprehensive approach to care that affects daily life for families. It calls for expanding research not just into the biology of the tumor, but into the development of effective treatments and 'comprehensive care' for affected children. This means looking at the full picture of what a family needs during a nine-month battle—from specialized medical access to support systems. For parents and healthcare providers, this is a formal push to move DIPG from a 'neglected' status into a priority category that could eventually lead to the first meaningful treatment breakthroughs in decades.